WO2001082933A3 - Compositions and methods for stabilizing modified tissue - Google Patents
Compositions and methods for stabilizing modified tissue Download PDFInfo
- Publication number
- WO2001082933A3 WO2001082933A3 PCT/US2001/012127 US0112127W WO0182933A3 WO 2001082933 A3 WO2001082933 A3 WO 2001082933A3 US 0112127 W US0112127 W US 0112127W WO 0182933 A3 WO0182933 A3 WO 0182933A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- tissue
- methods
- modification
- modified tissue
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000087 stabilizing effect Effects 0.000 title abstract 2
- 238000012986 modification Methods 0.000 abstract 3
- 230000004048 modification Effects 0.000 abstract 2
- 238000002203 pretreatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001253469A AU2001253469A1 (en) | 2000-04-27 | 2001-04-13 | Compositions and methods for stabilizing modified tissue |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55993300A | 2000-04-27 | 2000-04-27 | |
US09/559,933 | 2000-04-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001082933A2 WO2001082933A2 (en) | 2001-11-08 |
WO2001082933A3 true WO2001082933A3 (en) | 2002-07-18 |
Family
ID=24235662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/012127 WO2001082933A2 (en) | 2000-04-27 | 2001-04-13 | Compositions and methods for stabilizing modified tissue |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001253469A1 (en) |
WO (1) | WO2001082933A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
WO2013148895A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Ocular cross-linking system and method for sealing corneal wounds |
EP2830627B1 (en) | 2012-03-29 | 2024-05-01 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
WO2013149075A1 (en) | 2012-03-29 | 2013-10-03 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010809A1 (en) * | 1991-11-27 | 1993-06-10 | New York Blood Center, Inc. | Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
WO1993015234A1 (en) * | 1992-01-22 | 1993-08-05 | Novo Nordisk A/S | Activated factor xiii |
EP0628314A1 (en) * | 1993-06-04 | 1994-12-14 | Senju Pharmaceutical Co., Ltd. | Ophthalmic topical composition containing glucose for inhibiting injury to the corneal endothelium |
-
2001
- 2001-04-13 WO PCT/US2001/012127 patent/WO2001082933A2/en active Application Filing
- 2001-04-13 AU AU2001253469A patent/AU2001253469A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993010809A1 (en) * | 1991-11-27 | 1993-06-10 | New York Blood Center, Inc. | Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
WO1993015234A1 (en) * | 1992-01-22 | 1993-08-05 | Novo Nordisk A/S | Activated factor xiii |
EP0628314A1 (en) * | 1993-06-04 | 1994-12-14 | Senju Pharmaceutical Co., Ltd. | Ophthalmic topical composition containing glucose for inhibiting injury to the corneal endothelium |
Also Published As
Publication number | Publication date |
---|---|
WO2001082933A2 (en) | 2001-11-08 |
AU2001253469A1 (en) | 2001-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0209439B1 (en) | chapel lock mechanism for an explosion preventive controller, explosion preventive controller and method for attaching a chapel to a body of an explosion preventive controller. | |
WO2007030574A3 (en) | 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds | |
WO2006138046A3 (en) | Method and apparatus to facilitate handover | |
WO2004098494A3 (en) | Compounds, compositions, and methods | |
BR0114054A (en) | Method to Treat Allergies Using Substituted Pyrazoles | |
WO2000013266A3 (en) | A diode-pumped cascade laser for deep uv generation | |
EP2397107A3 (en) | Surgical scaffold | |
EP1475080A3 (en) | Cosmetic composition for the treatment of skin ageing and/or stressed skin | |
DK1818059T3 (en) | Preventive or therapeutic agent for glaucoma | |
BR0017157A (en) | 6-hydroxy-indazole derivatives for the treatment of glaucoma | |
ATE273694T1 (en) | TEAR SUBSTITUTES | |
WO2008058671A3 (en) | Projection apparatus having improved projection properties | |
DE602006010714D1 (en) | Ring anastomosis with closure agent | |
WO2003015725A3 (en) | Compositions comprising at least one hydroxide compound and at least one reducing agent, and methods for relaxing hair | |
WO2001082933A3 (en) | Compositions and methods for stabilizing modified tissue | |
WO2004052313A3 (en) | Anti-infectives | |
WO2004058150A3 (en) | Anti-infectives | |
AR026708A1 (en) | DERIVATIVES OF 5-HYDROXY-INDAZOL FOR THE TREATMENT OF GLAUCOMA | |
WO2002034233A3 (en) | Use of an association of a carotenoid and of an isoflavonoid for treating cutaneous symptoms of ageing | |
WO2003051299A3 (en) | Sulfhydryl rifamycins and uses thereof | |
BR0015630B1 (en) | insulating refractory material, article, and, aqueous composition for the manufacture of an insulating refractory material. | |
WO2002074193A3 (en) | METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES | |
WO2003059265A3 (en) | Compositions and methods for treating heart failure | |
BR0213179A (en) | Methods for treating dry eyes by a combination of an anti-inflammatory steroid and a muc-1 secretagogue | |
WO2006116374A3 (en) | Surface treatments for promoting selective tissue attachment to medical implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |